Terms: = Endocrine gland cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
28 results:
1. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
Xiong Y; Kong X; Mei H; Wang J; Zhou S
Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
[TBL] [Abstract] [Full Text] [Related]
3. High-Dose Rate Brachytherapy Combined with PD-1 Blockade as a treatment for Metastatic Adrenocortical Carcinoma - A Single Center Case Series.
Schwarzlmueller P; Corradini S; Seidensticker M; Zimmermann P; Schreiner J; Maier T; Triebig A; Knösel T; Pazos M; Pfluger T; Weigand I; Belka C; Ricke J; Reincke M; Schmidmaier R; Kroiss M
Horm Metab Res; 2024 Jan; 56(1):30-37. PubMed ID: 37748508
[TBL] [Abstract] [Full Text] [Related]
4. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
5. PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/gata3 axis.
Wang H; Zhou Y; Zhang S; Qi YA; Wang M
Oncol Res; 2021; 29(4):275-289. PubMed ID: 37303939
[TBL] [Abstract] [Full Text] [Related]
6. An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in Ovarian cancer.
Gonzalez-Ochoa E; Oza AM
Clin Cancer Res; 2023 Jul; 29(14):2563-2566. PubMed ID: 37191665
[TBL] [Abstract] [Full Text] [Related]
7. Vorinostat decrease M2 macrophage polarization through ARID1A
Hsieh TH; Hsu CY; Wu CW; Wang SH; Yeh CH; Cheng KH; Tsai EM
Biomed Pharmacother; 2023 May; 161():114500. PubMed ID: 36958195
[TBL] [Abstract] [Full Text] [Related]
8. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
Xie J; Wu ZB
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
[TBL] [Abstract] [Full Text] [Related]
9. A Population-Based Analysis of Outpatient Thyroidectomy: Safe and Under-Utilized.
Noel CW; Griffiths R; Siu J; Forner D; Urbach D; Freeman J; Goldstein DP; Irish JC; Higgins KM; Devon K; Pasternak JD; Eskander A
Laryngoscope; 2021 Nov; 131(11):2625-2633. PubMed ID: 34378810
[TBL] [Abstract] [Full Text] [Related]
10. Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules.
Jimenez-Sainz J; Jensen RB
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065235
[TBL] [Abstract] [Full Text] [Related]
11. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract] [Full Text] [Related]
12. 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells.
Greville G; Llop E; Howard J; Madden SF; Perry AS; Peracaula R; Rudd PM; McCann A; Saldova R
Clin Epigenetics; 2021 Feb; 13(1):34. PubMed ID: 33579350
[TBL] [Abstract] [Full Text] [Related]
13. Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.
Hu L; Xie X
Diagn Pathol; 2020 Dec; 15(1):142. PubMed ID: 33317559
[TBL] [Abstract] [Full Text] [Related]
14. Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
Huang NS; Cao YM; Lu ZW; Guan Q; Chen JY; Ma B; Chen TZ; Bai QM; Wang YL; Ji QH
Oral Oncol; 2021 Apr; 115():105092. PubMed ID: 33189578
[TBL] [Abstract] [Full Text] [Related]
15. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells.
Wei X; Yang J; Adair SJ; Ozturk H; Kuscu C; Lee KY; Kane WJ; O'Hara PE; Liu D; Demirlenk YM; Habieb AH; Yilmaz E; Dutta A; Bauer TW; Adli M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28068-28079. PubMed ID: 33097661
[TBL] [Abstract] [Full Text] [Related]
16. Gastric and adrenal metastasis from breast cancer: Case report and review of literature.
Tang T; Zhang L; Li C; Zhou T
Medicine (Baltimore); 2020 Jan; 99(3):e18812. PubMed ID: 32011488
[TBL] [Abstract] [Full Text] [Related]
17. gata3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract] [Full Text] [Related]
18. [A Case of Unclassified Sex Cord-Stromal Tumor Containing hCG-Positive Cells].
Toriyama F; Okuno Y; Mikami K; Uekusa T; Takeuchi T
Hinyokika Kiyo; 2019 Aug; 65(8):347-350. PubMed ID: 31501405
[TBL] [Abstract] [Full Text] [Related]
19. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.
Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS
Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183
[TBL] [Abstract] [Full Text] [Related]
20. Mammary Analogue Secretory Carcinoma of the Thyroid Mimicking Locally Advanced Papillary Thyroid Carcinoma: A Rare Case Report.
Liao H; Khan A; Miron PM; Cornejo KM
Int J Surg Pathol; 2018 Aug; 26(5):459-463. PubMed ID: 29228842
[TBL] [Abstract] [Full Text] [Related]
[Next]
